Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
about
Viral infection and human disease--insights from minimotifsIdentification of human embryonic progenitor cell targeting peptides using phage displayTargeting activated hepatic stellate cells (aHSCs) for liver fibrosis imagingLiposomes targeted by fusion phage proteinsEnhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.Bioengineering strategies for designing targeted cancer therapiesPaclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumorsIntegrin targeted delivery of chemotherapeuticsOn the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence mattersSystemic Administration of siRNA via cRGD-containing Peptide.In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150GluedInfluence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbitsThree-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models.Environmentally responsive peptides as anticancer drug carriers.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Cell adhesion molecules: role and clinical significance in cancer.Integrin targeted drug and gene delivery.Liposomal cancer therapy: exploiting tumor characteristics.Challenges in development of nanoparticle-based therapeutics.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Ligation strategies for targeting liposomal nanocarriers.Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues.Non-Invasive Detection of Lung Inflammation by Near-Infrared Fluorescence Imaging Using Bimodal Liposomes.Preparation and functional evaluation of RGD-modified streptavidin targeting to integrin-expressing melanoma cells.Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors.Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.Development of hydrogels and biomimetic regulators as tissue engineering scaffolds.Integrin-targeted paclitaxel nanoliposomes for tumor therapy.Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells.Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models.Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.
P2860
Q24647289-18EA3299-A46C-41F9-B2A9-8D76B65847C5Q28487510-48387878-32EA-4DEC-8141-AB40C136142FQ30395463-527E7F25-EFF3-4C76-8D77-2E7916261CF7Q33374206-794080C7-C7C8-4F76-9AD6-2B54842BAB92Q33596415-BBB15063-DE3A-4714-858F-2E4D1C40B408Q33701979-490DB027-5420-430C-A897-761495CA3E93Q34194191-21EB24E7-59E7-449B-B99F-17192EA8656BQ34647228-C8480717-AD47-4695-B2B4-872BCB546D1BQ34912725-932ABC8C-8FCA-4805-BAF2-603E2A14B5ABQ35256650-62C5016E-A684-47A0-9652-071A9CB8DD91Q35989535-6AF63D34-0C9C-4BB3-B009-84CF8DA4B982Q36149661-23A4B2F5-EB16-4F24-84DD-A622FC5BBDF4Q36440766-5E196065-D26B-462F-8A97-25E3082898EFQ36804990-7E7F5CBF-31D4-41CE-8050-341440D0A45FQ37039058-4421CBA2-D6E7-4F88-A86A-C475381FAD28Q37183977-894C6912-42D0-415F-B473-D019E271D393Q37506109-24570964-B5DE-49E1-9346-8013CB5EF031Q37560183-9CCF7758-8DF0-4110-927E-67667750D26BQ37572760-674720FF-E366-44F0-94F7-ED9D1FC601B3Q37631589-C1F6D63E-9C06-4E27-BCBD-2F4FDE55C057Q37679945-2E1DB757-BE63-4553-A131-EC818131D528Q37679954-E5A36D87-EB5B-40F3-947D-5C48AA5DFF78Q37992525-CEA9BCB1-A925-4726-9D8D-14298191D689Q38177370-9A3FABAA-4FFE-41FC-9363-01E08855AB0BQ38217461-FA954F5F-2D6B-4CB4-96C4-5FD30A880DDBQ38240154-16A54672-B1E3-4396-A2C5-413848BE9DC2Q38502588-391A10B9-6802-42FD-B4EA-4EA99843F19DQ38822703-2E44B055-C84A-4263-A566-B162E2022A6CQ39242833-87C06B8C-E5D6-42D7-AD48-7B888564C8FCQ39309330-3215BAE3-8EEF-46FD-84E2-B18888699B1DQ39622438-B9CD4887-1E55-4C70-B3E8-D7B808B4D2F7Q39636970-7AF1C081-0C5A-4A61-AFA4-47640B38E2C5Q39678154-76B56142-F91D-46FD-BBF6-D22F795A0E9AQ39691146-33D3D927-EE30-4692-9EDD-23778F6E7358Q39910188-6467C72D-6104-4164-88AC-71CC3833BDCBQ41195862-666BD75B-23AB-4FE1-862A-5AEB2B124ACAQ43650798-47843E01-764F-4230-8FE7-88223DF5F7D5Q48278086-49CCBFED-B4FC-4661-93E5-770C820FAA54Q50865530-082594B8-AF0A-4EED-A3BE-EE98DC5D11C3Q50897550-421D96B9-4E16-44D3-9460-428F990500A7
P2860
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@ast
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@en
type
label
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@ast
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@en
prefLabel
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@ast
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@en
P2093
P356
P1476
Novel RGD lipopeptides for the ...... ndothelial and melanoma cells.
@en
P2093
Miriam Bach
Peter Hölig
Roland E Kontermann
Sven Hoffmann
Thomas Nahde
Tina Völkel
P304
P356
10.1093/PROTEIN/GZH055
P50
P577
2004-05-01T00:00:00Z